CompletedPhase 1/2

Muscle-Sparing Effect Of Human Chorionic Gonadotropin (hCG) During a Very Low Calorie Diet (VLCD)

United States59 participantsStarted 2011-05

Plain-language summary

Subjects are female patients, randomized to HCG group or placebo group, during a prospective trial, in order to determine the significance, if any, of HCG on maintaining muscle mass during a very low calorie diet in order to demonstrate the potential significance of HCG administration on preserving lean body mass while losing weight.

Who can participate

Age range18 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Body Mass Index (BMI) greater than 30, * Female, * good health Exclusion Criteria: * complex medical history, * thyroid disease, * BMI less than 30, * psychological instability or history of eating disorder

What they're measuring

Weight loss achieved during a trial of HCG vs. Placebo and a very low calorie diet.

Timeframe: 30 days

Trial details

NCT IDNCT02427529

SponsorDr. Emma's Corporation

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-12

View on ClinicalTrials.gov More HCG trials